430 related articles for article (PubMed ID: 24655341)
1. Blood-brain barrier damages and intrathecal synthesis of anti-N-methyl-D-aspartate receptor NR2 antibodies in diffuse psychiatric/neuropsychological syndromes in systemic lupus erythematosus.
Hirohata S; Arinuma Y; Yanagida T; Yoshio T
Arthritis Res Ther; 2014 Mar; 16(2):R77. PubMed ID: 24655341
[TBL] [Abstract][Full Text] [Related]
2. Association of cerebrospinal fluid anti-Sm antibodies with acute confusional state in systemic lupus erythematosus.
Hirohata S; Sakuma Y; Yanagida T; Yoshio T
Arthritis Res Ther; 2014 Oct; 16(5):450. PubMed ID: 25273532
[TBL] [Abstract][Full Text] [Related]
3. Role of serum autoantibodies in blood brain barrier damages in neuropsychiatric systemic lupus erythematosus.
Hirohata S; Sakuma Y; Matsueda Y; Arinuma Y; Yanagida T
Clin Exp Rheumatol; 2018; 36(6):1003-1007. PubMed ID: 29846157
[TBL] [Abstract][Full Text] [Related]
4. Association of cerebrospinal fluid anti-NR2 glutamate receptor antibodies with diffuse neuropsychiatric systemic lupus erythematosus.
Arinuma Y; Yanagida T; Hirohata S
Arthritis Rheum; 2008 Apr; 58(4):1130-5. PubMed ID: 18383393
[TBL] [Abstract][Full Text] [Related]
5. Association of anti-NR2 and U1RNP antibodies with neurotoxic inflammatory mediators in cerebrospinal fluid from patients with neuropsychiatric systemic lupus erythematosus.
Kondo-Ishikawa S; Fujii T; Ishigooka N; Murakami K; Nakashima R; Hashimoto M; Yoshifuji H; Tanaka M; Ohmura K; Mimori T
Lupus; 2020 Nov; 29(13):1673-1682. PubMed ID: 32883159
[TBL] [Abstract][Full Text] [Related]
6. Antiribosomal P protein antibodies in cerebrospinal fluid are associated with neuropsychiatric systemic lupus erythematosus.
Yoshio T; Hirata D; Onda K; Nara H; Minota S
J Rheumatol; 2005 Jan; 32(1):34-9. PubMed ID: 15630721
[TBL] [Abstract][Full Text] [Related]
7. Clinical significance of anti-DNA/N-methyl-D-aspartate receptor 2 antibodies in de novo and post-steroid cases with neuropsychiatric systemic lupus erythematosus.
Fujieda Y; Mader S; Jeganathan V; Arinuma Y; Shimizu Y; Kato M; Oku K; Minami A; Shimizu C; Yasuda S; Atsumi T
Int J Rheum Dis; 2019 Mar; 22(3):443-448. PubMed ID: 30358102
[TBL] [Abstract][Full Text] [Related]
8. Association of antibodies to the NR1 subunit of N-methyl-D-aspartate receptors with neuropsychiatric systemic lupus erythematosus.
Ogawa E; Nagai T; Sakuma Y; Arinuma Y; Hirohata S
Mod Rheumatol; 2016; 26(3):377-83. PubMed ID: 26429674
[TBL] [Abstract][Full Text] [Related]
9. Role of Serum IL-6 in Neuropsychiatric Systemic lupus Erythematosus.
Hirohata S; Kikuchi H
ACR Open Rheumatol; 2021 Jan; 3(1):42-49. PubMed ID: 33393227
[TBL] [Abstract][Full Text] [Related]
10. Serum and cerebrospinal fluid autoantibodies in patients with neuropsychiatric lupus erythematosus. Implications for diagnosis and pathogenesis.
Fragoso-Loyo H; Cabiedes J; Orozco-Narváez A; Dávila-Maldonado L; Atisha-Fregoso Y; Diamond B; Llorente L; Sánchez-Guerrero J
PLoS One; 2008 Oct; 3(10):e3347. PubMed ID: 18836530
[TBL] [Abstract][Full Text] [Related]
11. Evaluation of blood-brain barrier function by quotient alpha2 macroglobulin and its relationship with interleukin-6 and complement component 3 levels in neuropsychiatric systemic lupus erythematosus.
Asano T; Ito H; Kariya Y; Hoshi K; Yoshihara A; Ugawa Y; Sekine H; Hirohata S; Yamaguchi Y; Sato S; Kobayashi H; Migita K; Ohira H; Hashimoto Y; Watanabe H
PLoS One; 2017; 12(10):e0186414. PubMed ID: 29036223
[TBL] [Abstract][Full Text] [Related]
12. Elevation of serum anti-glucose-regulated protein 78 antibodies in neuropsychiatric systemic lupus erythematosus.
Matsueda Y; Arinuma Y; Nagai T; Hirohata S
Lupus Sci Med; 2018; 5(1):e000281. PubMed ID: 30397496
[TBL] [Abstract][Full Text] [Related]
13. Impact analysis of autoantibody level and NR2 antibody level in neuropsychiatric SLE treated by methylprednisolone combined with MTX and DXM intrathecal injection.
Wang J; Zhao Y; Zhang J; Lei H; Zhu G; Fu B
Cell Biochem Biophys; 2014 Nov; 70(2):1005-9. PubMed ID: 24845150
[TBL] [Abstract][Full Text] [Related]
14. Systemic lupus erythematosus, the brain, and anti-NR2 antibodies.
Lauvsnes MB; Omdal R
J Neurol; 2012 Apr; 259(4):622-9. PubMed ID: 21909801
[TBL] [Abstract][Full Text] [Related]
15. Differential activation mechanisms of serum C5a in lupus nephritis and neuropsychiatric systemic lupus erythematosus.
Sakuma Y; Nagai T; Yoshio T; Hirohata S
Mod Rheumatol; 2017 Mar; 27(2):292-297. PubMed ID: 27319578
[TBL] [Abstract][Full Text] [Related]
16. A meta-analysis of serum and cerebrospinal fluid autoantibodies in neuropsychiatric systemic lupus erythematosus.
Ho RC; Thiaghu C; Ong H; Lu Y; Ho CS; Tam WW; Zhang MW
Autoimmun Rev; 2016 Feb; 15(2):124-38. PubMed ID: 26497108
[TBL] [Abstract][Full Text] [Related]
17. Understanding the Antibody Repertoire in Neuropsychiatric Systemic Lupus Erythematosus and Neuromyelitis Optica Spectrum Disorder: Do They Share Common Targets?
Mader S; Jeganathan V; Arinuma Y; Fujieda Y; Dujmovic I; Drulovic J; Shimizu Y; Sakuma Y; Stern JNH; Aranow C; Mackay M; Yasuda S; Atsumi T; Hirohata S; Diamond B
Arthritis Rheumatol; 2018 Feb; 70(2):277-286. PubMed ID: 29073350
[TBL] [Abstract][Full Text] [Related]
18. Blood-brain barrier disruption and neuroinflammation as pathophysiological mechanisms of the diffuse manifestations of neuropsychiatric systemic lupus erythematosus.
Duarte-Delgado NP; Vásquez G; Ortiz-Reyes BL
Autoimmun Rev; 2019 Apr; 18(4):426-432. PubMed ID: 30763633
[TBL] [Abstract][Full Text] [Related]
19. Anti-NR2 glutamate receptor antibodies and cognitive function in systemic lupus erythematosus.
Hanly JG; Robichaud J; Fisk JD
J Rheumatol; 2006 Aug; 33(8):1553-8. PubMed ID: 16881112
[TBL] [Abstract][Full Text] [Related]
20. Anti-NR2 antibodies, blood-brain barrier, and cognitive dysfunction.
Gulati G; Iffland PH; Janigro D; Zhang B; Luggen ME
Clin Rheumatol; 2016 Dec; 35(12):2989-2997. PubMed ID: 27357716
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
